Fund: FTBDNCH
Franklin Templeton - Franklin Biotechnology Discovery Fund A(acc)CHF-H1 | |
LU0959058974 | |
16-08-2013 | |
Equity | |
Equity Sectors - Health Care | |
Franklin Templeton Investment Funds | |
Franklin Advisers, Inc. | |
Evan McCulloch | |
CHF | |
1,000 | |
5.75% |
1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Výkonnosť fondu | -3.75% | -10.94% | -7.23% | -9.63% | 2.60% | -2.57% | -1.13% | 0.25% | -0.11% | N/A | |
Priemerná výkonnosť (36 meraní) | 0.01% | -2.60% | -3.02% | 0.29% | -0.28% | ||||||
Volatilita od priemernej výkonnosti | 9.04% | 33.23% | 6.32% | 4.80% | 3.21% |
Long | Short | Net | |
---|---|---|---|
Stock | 96.53% | 96.53% | |
Bond | |||
Other | |||
Cash | 3.47% | 3.47% |
Aktíva | 19 mil. |
Počet akcíí | 85 |
Počet dlhopisov | 1 |
Priebež. popl. | 1.82 |
z toho Mng. popl. | 1.50 |
Výk. prémia | |
Trans. popl. | 0.08 |
Dividenda | |
Dividendový výnos | |
Rozhodný dátum | |
Frekvencia výplaty |
Giant | 2.70% |
Large | 23.77% |
Medium | 21.92% |
Small | 15.13% |
Micro | 26.23% |
P/E | 15.72% |
P/BV | 3.42% |
Healthcare | 95.14% |
Derivatives | 3.47 |
Výnos do splatnosti p.a. | 4.42 |
Modifikovaná durácia | 0.01 |
AAA | 0.00 |
AA | 100.00 |
A | 0.00 |
BBB | 0.00 |
BB | 0.00 |
B | 0.00 |
Below B | 0.00 |
Not Rated | 0.00 |
United States | 83.78% |
Canada | 0.92% |
Latin America | |
United Kingdom | 4.10% |
Eurozone | 4.15% |
Europe - ex Euro | 3.02% |
Europe - Emerging | |
Africa | |
Middle East | |
Japan | |
Australasia | |
Asia - Developed | |
Asia - Emerging | |
Emerging Market | |
Developed Country | 95.98% |
Not Classified |
Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
---|---|---|---|---|---|
Vertex Pharmaceuticals Inc | Healthcare | 6.26% | Amgen Inc | Healthcare | 6.07% |
Regeneron Pharmaceuticals Inc | Healthcare | 5.42% | Gilead Sciences Inc | Healthcare | 5.23% |
Intra-Cellular Therapies Inc | Healthcare | 3.54% | argenx SE ADR | Healthcare | 3.25% |
Jazz Pharmaceuticals PLC | Healthcare | 3.06% | Federal Home Loan Banks | 2.92% | |
AstraZeneca PLC ADR | Healthcare | 2.7% | Merus NV | Healthcare | 2.61% |